On Friday, December 11, the U.S. Food and Drug Administration issued the first emergency use authorization (“EUA”) for a vaccine for the prevention of coronavirus disease 2019 (“COVID-19”) caused by severe acute respiratory syndrome coronavirus 2 (“SARS-CoV-2”) in individuals 16 years of age and older. The EUA allows the Pfizer-BioNTech COVID-19 Vaccine to be... READ MORE
Important Information for COVID-19 Vaccine Providers
Posted on December 15, 2020 in COVID-19 Daily Updates, Health Law News
Published by: Hall Render
